{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:24:03Z","timestamp":1789057443608,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ijcard.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T15:34:05Z","timestamp":1400254445000},"page":"274-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis"],"prefix":"10.1016","volume":"175","author":[{"given":"Morten","family":"W\u00fcrtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette O.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Kaltoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Tilsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen D.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-0865","authenticated-orcid":false,"given":"Erik L.","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.ijcard.2014.05.013_bb0005","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ijcard.2014.05.013_bb0010","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1160\/TH05-10-0653","article-title":"Dose- and time-dependent antiplatelet effects of aspirin","volume":"95","author":"Perneby","year":"2006","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ijcard.2014.05.013_bb0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12185-010-0652-3","article-title":"Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes","volume":"92","author":"Addad","year":"2010","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.05.013_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1160\/TH10-02-0082","article-title":"24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease","volume":"105","author":"Henry","year":"2011","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.013_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2010.02.025","article-title":"Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease","volume":"150","author":"Lordkipanidze","year":"2011","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.ijcard.2014.05.013_bb0030","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1538-7836.2012.04723.x","article-title":"The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes","volume":"10","author":"Rocca","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ijcard.2014.05.013_bb0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.110.960187","article-title":"Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease","volume":"4","author":"Capodanno","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ijcard.2014.05.013_bb0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH11-04-0216","article-title":"Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications","volume":"106","author":"Spectre","year":"2011","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.013_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2011.09.017","article-title":"Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocytemia","volume":"129","author":"Dillinger","year":"2012","journal-title":"Thromb Res"},{"issue":"20","key":"10.1016\/j.ijcard.2014.05.013_bb0050","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2011.12.042","article-title":"Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"59","author":"Dangas","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ijcard.2014.05.013_bb0055","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2010.07.016","article-title":"Stent thrombosis","volume":"56","author":"Holmes","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ijcard.2014.05.013_bb0060","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcin.2010.05.014","article-title":"Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets","volume":"3","author":"Wurtz","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.ijcard.2014.05.013_bb0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/heartjnl-2011-301164","article-title":"Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry","volume":"98","author":"Sambu","year":"2012","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.ijcard.2014.05.013_bb0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jacc.2008.05.031","article-title":"Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease","volume":"52","author":"Guthikonda","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.013_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1538-7836.2010.04115.x","article-title":"Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease","volume":"9","author":"Grove","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.ijcard.2014.05.013_bb0080","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2011.04304.x","article-title":"Increased platelet turnover in patients with previous definite stent thrombosis","volume":"9","author":"Grove","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ijcard.2014.05.013_bb0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.thromres.2011.07.019","article-title":"Influence of renal function and platelet turnover on the antiplatelet effect of aspirin","volume":"129","author":"Wurtz","year":"2012","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.ijcard.2014.05.013_bb0090","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199809103391107","article-title":"Thrombopoietin","volume":"339","author":"Kaushansky","year":"1998","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ijcard.2014.05.013_bb0095","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ijcard.2014.05.013_bb0100","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jacc.2012.07.004","article-title":"2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial","volume":"60","author":"Jensen","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"33","key":"10.1016\/j.ijcard.2014.05.013_bb0105","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.2174\/138161212803251862","article-title":"Platelet function testing in atherothrombotic disease","volume":"18","author":"Grove","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijcard.2014.05.013_bb0110","doi-asserted-by":"crossref","DOI":"10.3109\/09537104.2013.849804","article-title":"Rapid evaluation of platelet function using the Multiplate(R) Analyzer","author":"Wurtz","year":"2014","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.013_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH08-03-0186","article-title":"Immature platelets in patients with acute coronary syndromes","volume":"101","author":"Grove","year":"2009","journal-title":"Thromb Haemost"},{"issue":"15","key":"10.1016\/j.ijcard.2014.05.013_bb0120","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2011-06-359224","article-title":"Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target","volume":"119","author":"Pascale","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.013_bb0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","article-title":"Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs","volume":"69","author":"Reilly","year":"1987","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ijcard.2014.05.013_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance\u201d","volume":"53","author":"Santilli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ijcard.2014.05.013_bb0135","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1538-7836.2008.03133.x","article-title":"Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2","volume":"6","author":"Armstrong","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ijcard.2014.05.013_bb0140","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/hrt.2009.181107","article-title":"The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease","volume":"96","author":"Wurtz","year":"2010","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.013_bb0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1160\/TH12-01-0026","article-title":"Increased platelet aggregation and serum thromboxane levels in aspirin-treatedpatients with prior myocardial infarction","volume":"108","author":"Larsen","year":"2012","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ijcard.2014.05.013_bb0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.RES.0000214553.37930.3e","article-title":"De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin","volume":"98","author":"Evangelista","year":"2006","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.ijcard.2014.05.013_bb0155","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2008.05.032","article-title":"Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents","volume":"52","author":"Gori","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ijcard.2014.05.013_bb0160","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study","volume":"115","author":"Gurbel","year":"2007","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcard.2014.05.013_bb0165","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314009966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314009966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T14:35:14Z","timestamp":1597847714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314009966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0167527314009966"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.013","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}